Rheopheresis for severe peripheral arterial disease in hemodialysis patients: A clinical series.

Justine SolignacStanislas BatailleMaxime TouzotFlora BrunerDammar BouchouarebPhilippe BrunetChristophe RidelThomas Robert

Published in: Journal of clinical apheresis (2021)

Rheopheresis may improve clinical outcomes of CLTI in HD patients. The assessment of rheopheresis effectiveness needs to be confirmed by a multicenter randomized controlled trial, such as the ongoing project in France (RHEO-PAD, NCT: 03975946).

Keyphrases

randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
study protocol
peritoneal dialysis
prognostic factors
quality improvement
clinical trial
cross sectional
patient reported outcomes
drug induced